All Stories

  1. Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

    Article • PLoS ONE, June 2019, PLOS

    Dr Mark W Lowdell

  2. Natural killer cell cytotoxicity is a predictor of outcome for patients with high risk myelodysplastic syndrome and oligoblastic acute myeloid leukemia treated with azacytidine

    Article • Leukemia & Lymphoma, April 2019, Taylor & Francis

    Vasiliki Pappa, Dr Maria K Angelopoulou, Dr Mark W Lowdell, Professor Panagiotis Tsirigotis

  3. Decellularized material as scaffolds for tissue engineering studies in long gap esophageal atresia

    Article • Expert Opinion on Biological Therapy, March 2017, Taylor & Francis

    Dr Mark W Lowdell

  4. Tissue banking in ENT: challenges and methods

    Article • The Journal of Laryngology & Otology, June 2013, Cambridge University Press

    Dr Mark W Lowdell